Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07221409

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Pilot Study to Assess Safety, Tolerability and Efficacy of Virtual Reality in Cancer Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer-generated environments that simulate the real world or imagined settings. The VR intervention consists of a preloaded with immersive environments designed to engage the senses through simulated sights and sounds. This may include a walk through of a serene forest, exploring vibrant coral reefs, swimming with dolphins, or standing at the base of a majestic waterfall. These environments are created to provide a relaxing and engaging experience. Completing the VR intervention may be a safe and effective way to improve quality of life, reduce anxiety, enhance focus, and promote healthy living for cancer patients undergoing treatment.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire AdministrationParticipants will complete pre- and post-intervention questionnaires to assess symptoms of anxiety, depression, and fatigue.
OTHERVirtual Reality (VR) InterventionParticipants will engage in a single-session immersive Virtual Reality (VR) experience lasting approximately 20-30 minutes. The VR content will include calming, guided experiences such as nature scenes, meditation, or breathing exercises designed to promote relaxation and reduce psychological distress. The intervention will be administered in a clinical setting.

Timeline

Start date
2025-10-08
Primary completion
2027-10-08
Completion
2027-10-08
First posted
2025-10-27
Last updated
2026-04-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07221409. Inclusion in this directory is not an endorsement.